{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:43Z","timestamp":1790484163452,"version":"4.1.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Group B streptococcus (GBS) or <jats:italic>Streptococcus agalactiae<\/jats:italic> is an opportunistic pathogen that causes serious illness in newborns, pregnant women, and adults. However, insufficient detection methods and disease prevention programs have contributed to an increase in the incidence and fatality rates associated with this pathogen in non-neonatal patients. This study aimed to investigate factors of the observed increased incidence by investigation of serotype distribution, virulence factors, and antimicrobial susceptibility patterns from invasive GBS disease among non-neonatal patients in Thailand. During 2017\u20132018, a total of 109 <jats:italic>S. agalactiae<\/jats:italic> isolates were collected from non-pregnant patients. There were 62 males and 47 females, with an average age of 63.5 years (range: 20 \u2013 96). Serotypes were determined by latex agglutination assay and multiplex polymerase chain reaction (PCR)-based assay. Among those isolates, seven virulence genes (<jats:italic>rib<\/jats:italic>, <jats:italic>bca<\/jats:italic>, <jats:italic>pavA<\/jats:italic>, <jats:italic>lmb<\/jats:italic>, <jats:italic>scpB<\/jats:italic>, <jats:italic>cylE<\/jats:italic>, and <jats:italic>cfb<\/jats:italic>) were detected by PCR amplification, and were determined for their susceptibility to 20 antimicrobial agents using a Sensititre<jats:sup>TM<\/jats:sup> Streptococcus species STP6F AST plate. Among the study isolates, serotype III was predominant (52.3%), followed by serotype V and serotype VI (13.8% for each), serotype Ib (11.9%), and other serotypes (8.2%). Of the seven virulence genes, <jats:italic>pavA<\/jats:italic> was found in 67.0%. Except for one, there were no significant differences in virulence genes between serotype III and non-serotype III. Study isolates showed an overall rate of non-susceptibility to penicillin, the first-line antibiotic, of only 0.9%, whereas the resistance rates measured in tetracycline, clindamycin, azithromycin, and erythromycin were 41.3, 22.0, 22.0, and 22.0%, respectively. Strains that were resistant to all four of those drugs were significantly associated with non-serotype III (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Using multi-locus sequence typing (MLST), 40.0% of the four-drug-resistant isolates belonged to serotype VI\/ST1, followed by serotype Ib\/ST1 (35.0%). Cluster analysis with global GBS isolates suggested that the multiple drug-resistant isolates to be strongly associated with the clonal complex (CC) 1 (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Compared to the 2014 study of 210 invasive GBS isolates conducted in 12 tertiary hospitals in Thailand, the proportion of serotype III has dramatically dropped from nearly 90% to about 50%. This suggests that resistances to the second-line antibiotics for GBS might be the selective pressure causing the high prevalence of non-serotype III isolates.<\/jats:p>","DOI":"10.3389\/fmicb.2021.719353","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T06:02:10Z","timestamp":1631080930000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Emergence of Multi-Drug Resistance and Its Association With Uncommon Serotypes of Streptococcus agalactiae Isolated From Non-neonatal Patients in Thailand"],"prefix":"10.3389","volume":"12","author":[{"given":"Orawan","family":"Tulyaprawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujiraphong","family":"Pharkjaksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Kumar","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Popchai","family":"Ngamskulrungroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10096-008-0565-8","article-title":"Invasive group B Streptococcus (GBS) disease in Norway 1996\u20132006.","volume":"27","author":"Bergseng","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/infdis\/173.2.365","article-title":"Invasive group B Streptococcal disease: the emergence of serotype V.","volume":"173","author":"Blumberg","year":"1996","journal-title":"J. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0220990","DOI":"10.1371\/journal.pone.0220990","article-title":"Knowledge and use of antibiotics in Thailand: a 2017 national household survey.","volume":"14","author":"Chanvatik","year":"2019","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1128\/iai.70.5.2408-2413.2002","article-title":"The group B streptococcal C5a peptidase is both a specific protease and an Invasin.","volume":"70","author":"Cheng","year":"2002","journal-title":"Infect. Immun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.pedn.2004.05.012","article-title":"A history of neonatal group B Streptococcus with its related morbidity and mortality rates in the United States.","volume":"19","author":"Dermer","year":"2004","journal-title":"J. Pediatr. Nurs."},{"key":"B6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1099\/jmm.0.022616-0","article-title":"Antimicrobial resistance in group B Streptococcus: the Australian experience.","volume":"60","author":"Garland","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jac\/dkp458","article-title":"Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone.","volume":"65","author":"Gaudreau","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04041-0","article-title":"Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005\u20132019.","author":"Graux","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12879-015-1266-4","article-title":"Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988.","volume":"15","author":"Gudj\u00f3nsd\u00f3ttir","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/1040841x.2020.1758626","article-title":"A review of antibiotic resistance in Group B Streptococcus: the story so far.","volume":"46","author":"Hayes","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1086\/432804","article-title":"Group B streptococcal infections in elderly adults.","volume":"41","author":"High","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mimet.2009.11.010","article-title":"A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) ofStreptococcus agalactiae.","volume":"80","author":"Imperi","year":"2010","journal-title":"J. Microbiol. Methods"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3201\/eid2210.151436","article-title":"Hypervirulent clone of group B Streptococcus serotype III sequence type 283, Hong Kong, 1993\u20132012.","volume":"22","author":"Ip","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3389\/fmicb.2016.01308","article-title":"Molecular characterization of Streptococcus agalactiae causing community-and hospital-acquired infections in Shanghai, China.","volume":"7","author":"Jiang","year":"2016","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1128\/JCM.41.6.2530-2536.2003","article-title":"Multilocus sequence typing system for group B streptococcus.","volume":"41","author":"Jones","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12917-017-1322-y","article-title":"Biofilm production and other virulence factors in Streptococcus spp. isolated from clinical cases of bovine mastitis in Poland.","volume":"13","author":"Kaczorek","year":"2017","journal-title":"BMC Vet. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/pathogens9070526","article-title":"Increasing resistance and changes in distribution of serotypes of Streptococcus agalactiae in Poland.","volume":"9","author":"Kaminska","year":"2020","journal-title":"Pathogens"},{"key":"B18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12879-019-4177-y","article-title":"Emerging serotype III sequence type 17 group B Streptococcus invasive infection in infants: the clinical characteristics and impacts on outcomes.","volume":"19","author":"Kao","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mcp.2017.06.007","article-title":"Development of a multiplex PCR for identification of \u03b2-hemolytic streptococci relevant to human infections and serotype distribution of invasive Streptococcus agalactiae in Thailand.","volume":"36","author":"Kerdsin","year":"2017","journal-title":"Mol. Cell. Prob."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/aac.00185-08","article-title":"First molecular characterization of group B Streptococci with reduced penicillin susceptibility.","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13251","DOI":"10.1073\/pnas.94.24.13251","article-title":"Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle\/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.","volume":"94","author":"Li","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jmii.2014.11.002","article-title":"Clonal dissemination of invasive and colonizing clonal complex 1 of serotype VI group B Streptococcus in central Taiwan.","volume":"49","author":"Lin","year":"2016","journal-title":"J. Microbiol. Immunol. Infec."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1700473","DOI":"10.2807\/1560-7917.ES.2018.23.21.1700473","article-title":"Increasing macrolide resistance among Streptococcus agalactiae causing invasive disease in non-pregnant adults was driven by a single capsular-transformed lineage, Portugal, 2009 to 2015.","volume":"23","author":"Lopes","year":"2018","journal-title":"Eurosurveillance"},{"key":"B24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3389\/fmicb.2017.00499","article-title":"Streptococcus agalactiae causing neonatal infections in Portugal (2005\u20132015): diversification and emergence of a CC17\/PI-2b multidrug resistant sublineage.","volume":"8","author":"Martins","year":"2017","journal-title":"Front. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1128\/jcm.05488-11","article-title":"Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.","volume":"50","author":"Martins","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1128\/jcm.01183-16","article-title":"Molecular characteristics of group B Streptococci isolated from adults with invasive infections in Japan.","volume":"54","author":"Morozumi","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12879-021-05820-6","article-title":"Analysis of virulence factors and antibiotic resistance genes in group B Streptococcus from clinical samples.","volume":"21","author":"Mudzana","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B28","doi-asserted-by":"crossref","first-page":"115005","DOI":"10.1016\/j.diagmicrobio.2020.115005","article-title":"Streptococcus agalactiae infections and clinical relevance in adults, Thailand.","volume":"97","author":"Paveenkittiporn","year":"2020","journal-title":"Diagnost. Microbiol. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/07853890.2021.1930138","article-title":"Incidence of invasive Group B Streptococcus (iGBS) infections and the factors associated with iGBS mortality in adults during 2013\u20132017: a retrospective study at Thailand\u2019s largest national tertiary referral center.","volume":"53","author":"Phoompoung","year":"2021","journal-title":"Ann. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2958.2001.02211.x","article-title":"Genetic basis for the beta-haemolytic\/cytolytic activity of group B Streptococcus.","volume":"39","author":"Pritzlaff","year":"2001","journal-title":"Mol. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e20191881","DOI":"10.1542\/peds.2019-1881","article-title":"Management of infants at risk for group B streptococcal disease.","volume":"144","author":"Puopolo","year":"2019","journal-title":"Pediatrics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e014634","DOI":"10.1136\/bmjopen-2016-014634","article-title":"Outcome of a screening programme for the prevention of neonatal invasive early-onset group B Streptococcus infection in a UK maternity unit: an observational study.","volume":"7","author":"Rao","year":"2017","journal-title":"BMJ Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/1574-6976.12071","article-title":"Group B Streptococcal haemolysin and pigment, a tale of twins.","volume":"38","author":"Rosa-Fraile","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/jcm.02399-13","article-title":"Evaluation of the Bruker MALDI Biotyper for identification of Gram-positive rods: development of a diagnostic algorithm for the clinical laboratory.","volume":"52","author":"Schulthess","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dkq037","article-title":"Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals.","volume":"65","author":"Schwarz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s15010-007-7251-0","article-title":"Invasive group B Streptococcal disease in non-pregnant adults.","volume":"36","author":"Sendi","year":"2008","journal-title":"Infection"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1017\/S0950268806007515","article-title":"Distribution of novel and previously investigated virulence genes in colonizing and invasive isolates of Streptococcus agalactiae.","volume":"135","author":"Smith","year":"2007","journal-title":"Epidemiol. Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2471\/blt.17.199679","article-title":"Antibiotic distribution channels in Thailand: results of key-informant interviews, reviews of drug regulations and database searches.","volume":"96","author":"Sommanustweechai","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3109\/00365548.2013.810814","article-title":"Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil.","volume":"45","author":"Souza","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/j.1469-0691.2011.03628.x","article-title":"Invasive group B Streptococcal infections in adults, France (2007\u20132010).","volume":"17","author":"Tazi","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1128\/jcm.01128-15","article-title":"Emergence of serotype IV group B Streptococcus adult invasive disease in Manitoba and Saskatchewan, Canada, is driven by clonal sequence type 459 strains.","volume":"53","author":"Teatero","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.micinf.2007.02.015","article-title":"Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb.","volume":"9","author":"Tenenbaum","year":"2007","journal-title":"Microb. Infect."},{"key":"B43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jac\/dkz465","article-title":"Heterogeneity of penicillin-non-susceptible group B Streptococci isolated from a single patient in Germany.","volume":"75","author":"van der Linden","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/jcm.00810-10","article-title":"Group B streptococcal disease in nonpregnant patients: emergence of highly resistant strains of serotype Ib in Taiwan in 2006 to 2008.","volume":"48","author":"Wang","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamainternmed.2018.7269","article-title":"Epidemiology of invasive group B Streptococcal infections among nonpregnant adults in the United States, 2008-2016.","volume":"179","author":"Watkins","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"B46","author":"Wayne","year":"2011","journal-title":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing."},{"key":"B47","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1046\/j.1365-2672.83.s1.3.x","article-title":"Biology of streptococcal capsular polysaccharides.","volume":"83","author":"Wessels","year":"1997","journal-title":"J. Appl. Microbiol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3343\/alm.2019.39.4.414","article-title":"First case in Korea of group B Streptococcus with reduced penicillin susceptibility harboring amino acid substitutions in penicillin-binding protein 2X.","volume":"39","author":"Yi","year":"2019","journal-title":"Ann. Lab. Med."},{"key":"B49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1469-0691.2007.01914.x","article-title":"Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B Streptococcus) isolates from Australasian patients belonging to different age groups.","volume":"14","author":"Zhao","year":"2008","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.719353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T06:02:17Z","timestamp":1631080937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.719353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":49,"alternative-id":["10.3389\/fmicb.2021.719353"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.719353","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"article-number":"719353"}}